Browse the full record of transactions filed by BIOGEN INC.. Director active across 1 company, notably Sangamo Therapeutics, INC. In total, 12 disclosures have been logged. Split: 0 buy · 12 sells. Total volume traded: €2.9m. History available since 26 November 2021. The latest transaction was disclosed on 28 December 2021 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations12 total
2,764 shares@ US$8.51010.014% mcap1.4% of flowCommon StockSEC:0000875045-21-000061
2,764 shares@ US$8.51010.014% mcap0.7% of flowCommon StockSEC:0000875045-21-000061:0
81,187 shares@ US$8.55470.42% mcap42.8% of flowCommon StockSEC:0000875045-21-000060
81,187 shares@ US$8.55470.42% mcap21.4% of flowCommon StockSEC:0000875045-21-000060:0
23,660 shares@ US$8.56050.12% mcap12.5% of flowCommon StockSEC:0000875045-21-000059
23,660 shares@ US$8.56050.12% mcap6.2% of flowCommon StockSEC:0000875045-21-000059:0
52,178 shares@ US$8.51770.27% mcap27.5% of flowCommon StockSEC:0000875045-21-000058
52,178 shares@ US$8.51770.27% mcap13.7% of flowCommon StockSEC:0000875045-21-000058:0
730 shares@ US$8.52490.0037% mcap0.2% of flowCommon StockSEC:0000875045-21-000057:0
730 shares@ US$8.52490.0037% mcap0.4% of flowCommon StockSEC:0000875045-21-000057
28,884 shares@ US$8.60110.15% mcap7.7% of flowCommon StockSEC:0000875045-21-000055:0
28,884 shares@ US$8.60110.15% mcap15.5% of flowCommon StockSEC:0000875045-21-000055
About BIOGEN INC.
BIOGEN INC. is a director and insider at Sangamo Therapeutics, INC.